SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001008848-13-000067
Filing Date
2013-09-18
Accepted
2013-09-18 17:20:21
Documents
5
Period of Report
2013-07-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K AMENDMENT report_ngsxamendment-0913.htm 8-K/A 41118
2 E&Y CONSENT report_ngsxamendment-ex231.htm EX-23.1 5721
3 NEUROGESX ANNUAL FINANCIAL STATEMENTS report_ngsxamendment-ex992.htm EX-99.2 1125226
4 NEUROGESX SIX MONTH FINANCIAL STATEMENTS report_ngsxamendment-ex993.htm EX-99.3 564313
5 NEUROGESX PRO FORMA FINANCIAL STATEMENT report_ngsxamendment-ex994.htm EX-99.4 539203
  Complete submission text file 0001008848-13-000067.txt   2276603
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50513 | Film No.: 131104160
SIC: 2836 Biological Products, (No Diagnostic Substances)